grepafloxacin has been researched along with Community Acquired Infection in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dutchman, DA; Maroli, A; O'Doherty, B; Pettit, R | 1 |
| Lexchin, J | 1 |
| Churchyard, GA; Dylewski, JS; Hagberg, L; Moola, S; Sedani, S; Staley, H | 1 |
2 trial(s) available for grepafloxacin and Community Acquired Infection
| Article | Year |
|---|---|
Randomized, double-blind, comparative study of grepafloxacin and amoxycillin in the treatment of patients with community-acquired pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Bacteria; Community-Acquired Infections; Double-Blind Method; Female; Fluoroquinolones; Hematologic Tests; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Patient Dropouts; Penicillins; Piperazines; Pneumonia, Bacterial; Quinolones; Treatment Outcome | 1997 |
A multicenter study of grepafloxacin and clarithromycin in the treatment of patients with community-acquired pneumonia.
Topics: Adult; Aged; Anti-Infective Agents; Clarithromycin; Community-Acquired Infections; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Male; Middle Aged; Piperazines; Pneumonia, Bacterial; Prospective Studies; Treatment Outcome | 1999 |
2 other study(ies) available for grepafloxacin and Community Acquired Infection
| Article | Year |
|---|---|
New antibiotic approved for community-acquired infections.
Topics: Anti-Infective Agents; Bronchitis; Community-Acquired Infections; Contraindications; Fluoroquinolones; Humans; Piperazines; Pneumonia; Quinolones; Sexually Transmitted Diseases; United States; United States Food and Drug Administration | 1998 |
Drug not considered a first-line agent.
Topics: Anti-Infective Agents; Community-Acquired Infections; Drug Prescriptions; Drug Resistance, Microbial; Fluoroquinolones; Humans; Piperazines; Pneumonia; Practice Guidelines as Topic; Quinolones | 1998 |